The Scientist

» cancer immunology

Most Recent

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

image: Neoantigens Enable Personalized Cancer Immunotherapy

Neoantigens Enable Personalized Cancer Immunotherapy

By | April 1, 2017

Tumors’ mutations can encode the seeds of their own destruction, in the form of immunogenic peptides recognized by T cells.

1 Comment

image: Infographic: Targeting Cancer Antigens

Infographic: Targeting Cancer Antigens

By | April 1, 2017

Neoantigens may serve as valuable targets for new immunotherapies.

0 Comments

image: AACR Q&A: Elaine Mardis

AACR Q&A: Elaine Mardis

By | April 18, 2016

The genomics pioneer shares the sessions she most looks forward to at this year’s American Association for Cancer Research annual meeting.

0 Comments

image: Napster Cofounder Launches Cancer Initiative

Napster Cofounder Launches Cancer Initiative

By | April 13, 2016

Billionaire Silicon Valley entrepreneur Sean Parker donates $250 million to unite the cancer research community around the common goal of developing new immunotherapies.

0 Comments

image: Immune Influence

Immune Influence

By | April 1, 2016

In recent years, research has demonstrated that microbes living in and on the mammalian body can affect cancer risk, as well as responses to cancer treatment.

0 Comments

image: Microbes Meet Cancer

Microbes Meet Cancer

By | April 1, 2016

Understanding cancer’s relationship with the human microbiome could transform immune-modulating therapies.

4 Comments

image: Cancer Be Damned

Cancer Be Damned

By | April 1, 2016

Teenager Lauren Bendesky turned her cancer diagnosis on its head, using herself as a research subject to test potential therapies.

2 Comments

image: Mutations Not Tied to Metastasis

Mutations Not Tied to Metastasis

By | February 25, 2016

Clinical cases link immune changes to a cancer’s spread through the body, but find no role for so-called “driver” mutations.

3 Comments

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

Popular Now

  1. A Coral to Outlast Climate Change
  2. Antarctica Is Turning Green
  3. How to Tell a Person’s “Brain Age”
  4. Life Science Funding Cuts Leaked
    The Nutshell Life Science Funding Cuts Leaked

    According to a document posted online less than a day before the release of the official 2018 budget proposal, the National Institutes of Health could face even deeper cuts than previously suggested by the Trump administration.

AAAS